Crescent Capital Partners
Claire Chacko is a seasoned financial professional with extensive experience in financial management and accounting. Currently serving as Financial Controller at Crescent Capital Partners since April 2022, Claire also holds the position of Senior Manager - Family Office at Chapman Eastway since January 2019. Prior roles include Senior Manager at Grant Thornton Australia from November 2011 to January 2019, Senior Accountant at Brookfield Multiplex for a brief period in 2011, and Supervisor at HLB Mann Judd from December 2006 to January 2011. Claire began a career in accounting as an Undergraduate/Cadet Accountant at Crowe Horwath Australia from January 2004 to December 2006. Claire Chacko holds a Bachelor's degree in Business (Finance) from Charles Sturt University, completed between 2004 and 2007, and is a member of Chartered Accountants Australia and New Zealand, with qualifications attained from 2008 to 2009.
This person is not in any teams
Crescent Capital Partners
Crescent Capital Partners (Crescent) is a Sydney-based private equity firm investing in middle-market companies located in Australia and New Zealand with enterprise values between A$100 million and A$500 million. Crescent was formed in 2000 and has established itself as one of Australasia’s leading middle market private equity firms with its last three funds ranked as top quartile global funds (measured in either USD or AUD), as measured by Cambridge Associates. Crescent’s investment focus is on high-growth companies and sectors, or in industries that are undergoing structural change or that lend themselves to consolidation. Crescent’s role is to accelerate and support the senior management teams of these businesses in reaching their aspirational targets and goals. Crescent has a differentiated investment process that combines thematic and proprietary deal sourcing, with a disciplined and analytical approach to investing and a proactive approach to driving value at portfolio companies. Crescent has particular experience and skills in financial services, healthcare, branded and industrial businesses. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made in the past 10 years. Crescent has had a strong track record in delivering superior returns to investors through successful exits. Crescent is now investing our $1 billion Crescent VII (2023 vintage).